Pliant Therapeutics, Inc. · NASDAQ:PLRX
The Vanguard Group's stake in Pliant Therapeutics, Inc. fell to 4.89% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group's stake in Pliant Therapeutics, Inc. fell to 4.89%, 3,002,348 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 4.89%
- Shares
- 3,002,348
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.89% | 3,002,348 |
Source
Related
- Pliant Therapeutics, Inc.
- The Vanguard Group
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026